Sickle Cell Anemia Genetic Screening: How It Works, Results and What to Expect

Sickle cell anemia genetic screening looks for changes in the HBB gene that affect hemoglobin, the oxygen-carrying protein in red blood cells. It can confirm sickle cell disease, identify sickle cell trait, support reproductive planning, and clarify results from other blood tests.

Overview: what sickle cell anemia genetic screening shows

Sickle cell anemia genetic screening is a test process used to detect inherited changes that affect hemoglobin. It can show whether a person has sickle cell disease, carries sickle cell trait, or has another hemoglobin variant that may be relevant to their health or family planning. The testing process usually starts with analysis of a blood sample and may include DNA testing when a more precise genetic answer is needed.

Sickle cell anemia is one form of sickle cell disease, a group of inherited blood disorders in which red blood cells can become rigid and sickle-shaped under certain conditions. These cells may break down sooner than usual and can sometimes obstruct blood flow. Screening is valuable because it can identify the condition or carrier status even before symptoms develop.

Newborn screening programs in many countries routinely test babies for sickle cell disease. Testing may also be offered to adults before pregnancy, to people with a family history of sickle cell disease or trait, and to those whose blood tests suggest an inherited hemoglobin condition. A result is most useful when considered alongside personal history, family background, and, when appropriate, genetic counseling.

How screening works and who may benefit

Most initial sickle cell tests examine the types of hemoglobin present in a blood sample. Hemoglobin electrophoresis, high-performance liquid chromatography, and similar laboratory methods separate and measure hemoglobin types, including hemoglobin A, hemoglobin S, hemoglobin C, and fetal hemoglobin. These tests can often distinguish sickle cell trait from sickle cell disease.

Genetic testing examines the HBB gene directly. It may be recommended when hemoglobin testing is unclear, when a person has recently received a blood transfusion, or when clinicians need to identify the exact hemoglobin variants present. A blood sample is common, though some laboratories may use a saliva or cheek-swab sample for DNA analysis.

Screening can be particularly helpful for people who have a known family history of sickle cell disease or trait, a partner with sickle cell trait or another hemoglobin variant, ancestry from regions where hemoglobin disorders are more common, or unexplained anemia. It may also be considered before pregnancy or during pregnancy. Testing is voluntary in most settings, and informed discussion helps individuals understand what the possible findings could mean.

• People planning a pregnancy who want to understand inherited risks
• Partners of someone known to have sickle cell trait or disease
• Individuals with a relative affected by sickle cell disease
• People with an abnormal newborn screen or abnormal hemoglobin test
• Individuals with unexplained anemia, red cell changes, or recurrent symptoms needing evaluation

What to expect: step-by-step testing and recovery

Before testing, a clinician may ask about family history, prior blood transfusions, pregnancy plans, medications, and symptoms. In most cases, no fasting or special preparation is required. However, it is important to tell the healthcare team about a blood transfusion received in recent months, as donor red blood cells can affect some hemoglobin test results.

For a blood-based test, a healthcare professional cleans the skin, usually at the inside of the elbow, and takes a small blood sample. The collection typically takes only a few minutes. The sample is sent to a laboratory for hemoglobin analysis and, if indicated, molecular genetic testing. Newborn screening is usually performed with a few drops of blood collected from the baby’s heel.

There is no significant recovery timeline. A person can generally return to normal activities immediately after the blood draw. Mild soreness, a small bruise, or brief light-headedness can occur and usually settles quickly. Applying gentle pressure to the site after collection can help reduce bruising.

The main benefits are early identification, clearer diagnosis, informed family planning, and timely referral for care where needed. Risks are minimal and mainly relate to routine blood collection, such as discomfort, bruising, or rarely infection at the needle site. Genetic results can also raise emotional or family concerns, so genetic counseling can be a helpful part of the process.

How long does it take to get results from a sickle cell test?

Turnaround time depends on the test, the laboratory, and whether confirmation is required. A routine hemoglobin screening test may be available within a few days, while genetic testing may take longer, often from several days to a few weeks. Newborn screening results are processed through public health systems and are communicated according to local procedures.

If the first test finds an unusual hemoglobin pattern, the laboratory or clinician may request a repeat sample or a more detailed test. This does not necessarily mean that a person has sickle cell disease; it may simply be necessary to distinguish between trait, disease, another hemoglobin variant, or the effects of a recent transfusion.

People awaiting results can ask which test was ordered, when results are expected, and who will explain them. A clinician, hematologist, or genetic counselor can place the findings in context and discuss whether relatives or a reproductive partner may also benefit from testing.

How to interpret sickle cell test results

Result terminology varies between laboratories, but common interpretations are straightforward when reviewed by a qualified clinician. A result showing mainly hemoglobin A without hemoglobin S generally means that sickle hemoglobin was not detected. A result with both hemoglobin A and hemoglobin S commonly suggests sickle cell trait, meaning the person carries one altered HBB gene copy.

A pattern with predominantly hemoglobin S and little or no hemoglobin A may suggest sickle cell disease, including sickle cell anemia. Other patterns may indicate a different form of sickle cell disease, such as hemoglobin SC disease or sickle beta-thalassemia. DNA testing can clarify the exact inherited variants when necessary.

Sickle cell trait usually does not develop into sickle cell disease. Most carriers lead healthy lives and do not experience the ongoing anemia or pain episodes associated with sickle cell disease. However, a carrier can pass the altered gene to children. If both biological parents carry certain hemoglobin gene variants, their children may have a chance of inheriting a clinically significant hemoglobin disorder.

Interpretation can be more complex after a blood transfusion, in very young infants, or when more than one hemoglobin variant is present. For this reason, a result should not be self-diagnosed from a laboratory report alone. Follow-up testing and counseling help ensure an accurate explanation.

What are the typical results of blood tests for sickle cell anemia?

Blood tests for sickle cell anemia may show changes related to chronic red blood cell breakdown and anemia. A complete blood count can show a low hemoglobin level and reduced red blood cell count. The red blood cells may also vary in size or shape on a blood film, and the reticulocyte count, which reflects new red blood cell production, may be elevated as the bone marrow responds to anemia.

Hemoglobin analysis is central to diagnosis. In classic sickle cell anemia, hemoglobin S is the predominant hemoglobin type, while hemoglobin A is absent or very low. Fetal hemoglobin may be present in varying amounts, especially in infants, and hemoglobin A2 may help clinicians assess whether beta-thalassemia is also involved.

Additional blood tests may show signs of increased red blood cell turnover, such as higher bilirubin or lactate dehydrogenase levels. These findings are not specific to sickle cell disease, so clinicians use them together with hemoglobin studies, genetic testing when needed, symptoms, and medical history. Ongoing assessment is usually led by a hematology team for people diagnosed with sickle cell disease.

What are 5 symptoms of sickle cell anemia?

Symptoms vary widely between individuals and can range from mild to more significant. They often begin in childhood in people with sickle cell anemia, although timing and severity differ. Sickle cell trait generally does not cause the typical symptoms of sickle cell disease.

Five common symptoms or health features associated with sickle cell anemia are:

• Anemia-related tiredness: reduced red blood cell survival can contribute to fatigue, weakness, or shortness of breath with exertion.
• Episodes of pain: pain can occur when sickled cells affect blood flow, often involving bones, chest, abdomen, or joints.
• Swelling of hands and feet: painful swelling may occur in young children.
• Jaundice: yellowing of the skin or whites of the eyes can result from faster red blood cell breakdown.
• Frequent infections: spleen function may be affected, increasing vulnerability to some infections.

Other possible concerns include delayed growth in children, vision problems, stroke risk, and acute chest syndrome. These complications do not affect everyone in the same way. Early specialist care, preventive measures, and an individualized management plan can reduce risks and support day-to-day wellbeing.

When to seek medical care

Anyone with a positive newborn screen, an abnormal sickle cell test, a known family history, or questions about carrier status should arrange a discussion with a doctor or genetic counselor. Prompt evaluation is important for infants and children with suspected sickle cell disease because early preventive care can make a meaningful difference.

A person known to have sickle cell disease should seek urgent medical assessment for fever, chest pain, difficulty breathing, sudden weakness or speech changes, severe headache, unusual sleepiness, persistent vomiting, severe or escalating pain, or painful prolonged erection. These symptoms can have several causes but require timely clinical attention in people with sickle cell disease.

For reproductive planning, both partners may consider screening before conception or as early as possible in pregnancy. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and care planning for international patients with inherited blood disorders.

Frequently asked questions

Is genetic screening the same as a sickle cell blood test?

They are related but not always identical. Hemoglobin tests analyze the types of hemoglobin in the blood, while genetic testing looks directly for changes in the HBB gene. A clinician may use one or both tests depending on the situation and the clarity of the initial results.

Can a person have sickle cell trait and not know it?

Yes. Most people with sickle cell trait have no usual symptoms of sickle cell disease and may not know they carry the gene variant until screening is performed. Knowing carrier status can be especially helpful for family planning and for informing healthcare professionals.

Does sickle cell trait turn into sickle cell anemia?

No. Sickle cell trait does not change into sickle cell anemia over time. Trait means a person inherited one altered hemoglobin gene copy, while sickle cell anemia generally occurs when a person inherits two altered copies associated with hemoglobin S.

Can a blood transfusion affect a sickle cell test?

Yes. A recent transfusion can introduce donor red blood cells containing hemoglobin A, which may make hemoglobin analysis more difficult to interpret. The healthcare team should be told about any recent transfusion and may recommend genetic testing or repeat testing at an appropriate time.

Should both partners be tested for sickle cell trait before pregnancy?

Testing both partners can provide clearer information about the chance of passing on sickle cell disease or another hemoglobin disorder. If one partner is found to carry a variant, testing the other partner and speaking with a genetic counselor can help explain possible outcomes and available options.

Can sickle cell anemia be diagnosed before birth?

Yes, prenatal diagnostic testing may be available when there is a known risk that a fetus could inherit sickle cell disease. These tests should be discussed with an obstetrician, genetic counselor, and appropriate specialist, as the options, timing, benefits, and limitations need individual consideration.

References

• Centers for Disease Control and Prevention
• National Heart, Lung, and Blood Institute
• American Society of Hematology
• MedlinePlus Genetics
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.